A Prospective Observational Study To Evaluate Long-Term Safety And Functional Status Of Subjects With Rheumatoid Arthritis Previously Enrolled In Studies Of CP-690,550.
Phase of Trial: Phase II/III
Latest Information Update: 26 Feb 2017
At a glance
- Drugs Tofacitinib (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Pfizer
- 28 Mar 2012 Actual patient number (162) added as reported by ClinicalTrials.gov.
- 28 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Apr 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.